Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02308657 · ClinicalTrials.gov registry record
Multicenter Observational Study of Myotonic Dystrophy Type 1
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 120
- Enrollment target
NCT02308657 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 120 participants.
The verdict
NCT02308657 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the best ways to assess how people are affected by myotonic dystrophy type 1 (DM1). The study will assess walking speed, muscle strength, muscle size, myotonia, heart rhythm, mental efficiency, and overall health. Participants will complete questionnaires to record their ideas about how they are affected by DM1. The study will evaluate people with DM1 over 1 year to determine how the condition changes over time. The study will identify biomarkers of DM1. Biomarkers are laboratory measurements that show the effects of DM1 on a person's muscle tissue or blood. Biomarkers are needed in future studies to determine how DM1 may respond to treatments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-11 |
| Est. Completion | 2017-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02308657
The ClinicalTrials.gov registry entry for NCT02308657 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02308657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02308657 about?
NCT02308657 is a clinical study titled "Multicenter Observational Study of Myotonic Dystrophy Type 1". The purpose of the study is to determine the best ways to assess how people are affected by myotonic dystrophy type 1 (DM1). The study will assess walking speed, muscle strength, muscle size, myotonia, heart rhythm, mental efficiency, and overall health. Participants will complete questionnaires to ...
What is the current status of trial NCT02308657?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2013-11. Estimated completion is 2017-10.
Who is sponsoring clinical trial NCT02308657?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.